每經AI快訊，3月(yue)(yue)3日，上海萊(lai)士(002252.SZ)公(gong)告稱，公(gong)司(si)(si)控(kong)股(gu)股(gu)東(dong)海盈康（青島）醫療科技有限(xian)公(gong)司(si)(si)計劃(hua)自公(gong)告披露之日起6個月(yue)(yue)內，通過(guo)集中競價(jia)交易(yi)方式增(zeng)(zeng)(zeng)(zeng)持(chi)公(gong)司(si)(si)股(gu)份，增(zeng)(zeng)(zeng)(zeng)持(chi)金額不(bu)(bu)低于2.5億元(yuan)，且不(bu)(bu)超過(guo)5億元(yuan)。增(zeng)(zeng)(zeng)(zeng)持(chi)旨在基(ji)于對(dui)公(gong)司(si)(si)未(wei)來發展的(de)信(xin)心和長期投資(zi)(zi)(zi)價(jia)值的(de)認同，增(zeng)(zeng)(zeng)(zeng)強投資(zi)(zi)(zi)者信(xin)心。增(zeng)(zeng)(zeng)(zeng)持(chi)計劃(hua)不(bu)(bu)設置價(jia)格區間，增(zeng)(zeng)(zeng)(zeng)持(chi)主體將擇機實施。增(zeng)(zeng)(zeng)(zeng)持(chi)資(zi)(zi)(zi)金來源包括自有資(zi)(zi)(zi)金及股(gu)份增(zeng)(zeng)(zeng)(zeng)持(chi)專項(xiang)貸款，其中專項(xiang)貸款資(zi)(zi)(zi)金占(zhan)比(bi)不(bu)(bu)超過(guo)90%。